We had our annual Diabetes Academy, a special event which brings together our researchers, clinicians, supporter, and patients to explore groundbreaking diabetes research and treatments and hear new ideas from the next generation of leaders. Topics included autoimmunity, technology and precision medicine, diversity of diabetes across a lifespan, and the evolution of diabetes care and research in the safety net.
Mark Anderson, MD, PhD accepts the prestigious 2024 William B. Coley Award for Distinguished Research in Basic and Tumor Immunology, which recognizes the groundbreaking discoveries in immune tolerance, self-antigen presentation, and the crucial role of AIRE in preventing autoimmunity that he and Christophe Benoist, MD, PhD, and Diane Mathis, PhD made at Harvard.
Our panel of UCSF experts explore the root causes of excess weight, how weight-loss drugs work, and their potential for transforming care for people with obesity and diabetes, delving into these emerging new therapies for what they mean for the future of the field, including the pioneering concept of precision nutrition.
Jeff Bluestone presents "Immune Tolerance: Traveling on the long road towards finding the Holy Grail" at our 20th Year Anniversary Symposium
This year's UCSF Diabetes Academy, hosted by UCSF Foundation, met virtually on October 6, 2021, uniting clinicians and scientists from across UCSF campuses to share the latest advances in diabetes research and care.
New technologies in the effort to discover a cure for type 1 diabetes include figuring out how to rewire the immune system by transplanting islets from donors.
Featuring speakers Julie Sneddon, UCSF, and Everett Meyer, Stanford; a special thanks goes out to Michelle Griffin and Karen Jordan.
